NOVO NORDISK A/S revenue for the last year amounted to 837.97 B MXN, the most of which — 784.19 B MXN — came from its highest performing source at the moment, Diabetes and Obesity Care, the year earlier bringing 540.80 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought NOVO NORDISK A/S 483.05 B MXN, and the year before that — 320.64 B MXN.